| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Sukhtian Faisal Ghiath is a Director at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $107K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2022 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 30,000 | $1.29 | $38,700.00 | +78.9% | -18.3% | -81.9% | |
| Dec 2, 2021 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 18,000 | $1.40 | $25,200.00 | +90.0% | +23.2% | -21.7% | |
| Apr 19, 2021 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 10,000 | $1.82 | $18,200.00 | +100.0% | +28.4% | -1.6% | |
| Sep 17, 2020 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 10,000 | $0.67 | $6,731.00 | New | - | - |